CVM GFI #126 BACPAC I-Intermediates in Drug Substance Synthesis Bulk Actives Postapproval Changes: Chemistry, Manufacturing, and Controls Documentation
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 1, 2006
July 27, 2021
b81e8e56-c453-49c6-880d-62c5dc8c17d6
Related Documents
CVM GFI #204 Active Controls in Studies to Demonstrate Effectiveness of a New Animal Drug for use in Companion Animals
Guidance DocumentDecember 1, 2015Center for Veterinary Medicine
CVM GFI #92 (VICH GL10(R)) Impurities In New Veterinary Drug Substances
Guidance DocumentNovember 26, 2007Center for Veterinary Medicine
CVM GFI #156 Comparability Protocols - Chemistry, Manufacturing, and Controls Information for New Animal Drugs
Guidance DocumentApril 4, 2016Center for Veterinary Medicine
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox